NCT06117904 is a NA clinical trial of MEBO ointment in Radiotherapy Side Effect, sponsored by Beni-Suef University.

Who is sponsoring NCT06117904?

NCT06117904 is sponsored by Beni-Suef University.

What drugs are being tested in NCT06117904?

Interventions in NCT06117904: MEBO ointment, Symptomatic treatment only.

What condition does NCT06117904 study?

NCT06117904 studies Radiotherapy Side Effect, Mucositis.

Is NCT06117904 still recruiting?

NCT06117904 is currently completed. Last updated 25 July 2024.

Last reviewed 2024-07-25 · How we verify

NCT06117904

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Adjunctive Treatments for the Prevention of Radiotherapy-Induced Mucositis

Completed NA Last updated 25 July 2024

What this trial tests

NA trial testing MEBO ointment in Radiotherapy Side Effect in 60 participants. Completed in 1 July 2024.

Timeline

1 January 2024

Primary endpoint
1 June 2024

1 July 2024

Quick facts

Lead sponsor	Beni-Suef University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	60
Start date	1 January 2024
Primary completion	1 June 2024
Estimated completion	1 July 2024
Sites	1 location across Egypt

Drugs / interventions tested

MEBO ointment — full drug profile →
Symptomatic treatment only — full drug profile →

Conditions studied

Radiotherapy Side Effect — all drugs for Radiotherapy Side Effect →
Mucositis — all drugs for Mucositis →

Sponsor

Beni-Suef University

Who can join

18 and older, any sex, with Radiotherapy Side Effect or Mucositis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Radiation therapy (RT) is used in at least 50% of cancer patients and is critical in treating and palliating tumor-related symptoms. Normal tissue radiation toxicity remains an overwhelming obstacle in treating cancer patients with localized tumors. Mucositis is the inflammation and ulceration of the oral and gastrointestinal mucosa observed with different cancer therapies. Oral mucositis is a common, severe, and debilitating complication of RT occurring several days to weeks after RT initiation.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Ionizing radiation: molecular mechanisms, biological effects, and therapeutic targets.
Wei W, Ren Y, Lan J, Yi J, et al · · 2026 · PMID 41507636 · DOI 10.1186/s43556-025-00358-4

Verify or expand the search:

Other recruiting trials for Radiotherapy Side Effect

Currently open trials in the same condition.

NCT06950073 — Curatively Intended Thoracic Reirradiation · recruiting
NCT06311955 — Clinical Study of Postoperative Carbon Ion Radiotherapy for Thymus Tumor With Residual Tumor · Phase 2 · recruiting
NCT07008716 — Omitting CTV for Primary Tumor in LS-SCLC · Phase 3 · recruiting
NCT06758830 — Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer. · Phase 2, PHASE3 · recruiting
NCT06752239 — Prophylactic Radiotherapy Optimization for Enhanced Thyroid Function Protection in NPC · Phase 3 · recruiting

Other Beni-Suef University trials

Trials by the same sponsor.

NCT07536347 — Effect of Adding PNF to IMT on Weaning Off MV · NA · not yet recruiting
NCT07494240 — Effects of Changes in Driving Pressure on Intraoperative Pulmonary Dynamic Compliance and PaO₂/FiO₂ Ratio in Laparoscopi · NA · not yet recruiting
NCT07506499 — Cardiac Rehabilitation in Decompensated Heart Failure · NA · recruiting
NCT07482631 — Robotic Glove Training on Hand Function in Unilateral Cerebral Palsy · NA · not yet recruiting
NCT07509736 — Effect of Pulmonary Rehabilitation in Females With Acute Exacerbation of COPD Induced by Biomass Fuel Smoke · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06117904 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Beni-Suef University
Last refreshed: 25 July 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06117904.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing